Bioequivalence risk assessment of oral formulations containing racemic ibuprofen through a chiral physiologically based pharmacokinetic model of ibuprofen enantiomers

  1. Reig-López, J.
  2. Cuquerella-Gilabert, M.
  3. Bandín-Vilar, E.
  4. Merino-Sanjuán, M.
  5. Mangas-Sanjuán, V.
  6. García-Arieta, A.
Revista:
European Journal of Pharmaceutics and Biopharmaceutics

ISSN: 1873-3441 0939-6411

Ano de publicación: 2024

Volume: 199

Tipo: Artigo

DOI: 10.1016/J.EJPB.2024.114293 GOOGLE SCHOLAR lock_openAcceso aberto editor